| Literature DB >> 32733868 |
Elisabetta Avitabile1, Laura Fusco2,3,4, Silvia Minardi5, Marco Orecchioni1, Barbara Zavan6,7, Acelya Yilmazer8,9, Martina Rauner10, Proto Pippia11, Ennio Tasciotti12, Lucia Gemma Delogu1,3,13.
Abstract
Prolonged exposure to microgravity (MG) during long-duration space flights is known to induce severe dysregulation of osteoblast functions connected to a significant bone loss, similar to the condition induced by osteoporosis. Hence, we here present MG as a promising model to challenge the effectiveness of new scaffolds designed for bone regeneration in counteracting bone loss. To this end, we carried out an integrative study aimed to evaluate, in the extreme condition of Random Positioning Machine-simulated MG, the osteoinductive potential of nanocrystalline magnesium-doped hydroxyapatite/type I collagen composite scaffold (MHA/Coll), that we previously demonstrated to be an excellent tool for bone tissue engineering. Initially, to test the osteoinductive properties of our bioinspired-scaffold, MHA/Coll structure was fully characterized under MG condition and compared to its static counterpart. Human bone marrow-derived mesenchymal stem cells were used to investigate the scaffold biocompatibility and ability to promote osteogenic differentiation after long-duration exposure to MG (up to 21 days). The results demonstrate that the nanostructure of MHA/Coll scaffold can alleviate MG-induced osteoblast dysfunction, promoting cell differentiation along the osteogenic lineage, with a consequent reduction in the expression of the surface markers CD29, CD44, and CD90. Moreover, these findings were corroborated by the ability of MHA/Coll to induce the expression of genes linked to osteogenesis, including alkaline phosphatase and osteocalcin. This study confirmed MHA/Coll capabilities in promoting osteogenesis even in extreme long-term condition of MG, suggesting MG as an effective challenging model to apply in future studies to validate the ability of advanced scaffolds to counteract bone loss, facilitating their application in translational Regenerative Medicine and Tissue Engineering.Entities:
Keywords: bone; microgravity; nanomaterials; random positioning machine; scaffolds; space biology; stem cells; tissue regeneration
Year: 2020 PMID: 32733868 PMCID: PMC7362936 DOI: 10.3389/fbioe.2020.00722
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Scaffold architectures. SEM structural characterization of MHA/Coll scaffold (A). The higher magnification micrograph of MHA/Coll (B) shows the collagen fibers with a full mineralization and an amorphous apatite phase. FTIR spectra showing the chemical interaction between the mineral phase and the type I collagen fibers of MHA/Coll (C). Evaluation of the mineral phase on MHA/Coll by TGA-DSC analysis (D). SEM micrographs of MHA/Coll structure evaluated after 21 days under gravity (G, 100×) (E) or microgravity (MG, 100×) conditions (F).
FIGURE 2SEM micrographs of MHA/Coll structure and cells morphology. SEM micrographs of MHA/Coll architecture under G condition (A) and MHA/Coll after MG exposure (B) (1000×). Induced hBM-MSCs morphology in the center of the scaffold surface after 21 days under G condition (C) and simulated MG condition (D). Induced hBM-MSCs connected together and attached onto the fibers of the scaffold under G condition (E) and after MG exposure (F) (2000×). White arrows indicate changes in cell morphology induced by MG exposure.
FIGURE 3Viability assay of hBM-MSCs cultured on MHA/Coll scaffolds. hBM-MSCs were cultured on MHA/Coll scaffolds (red) for 7, 14, and 21 days under G or MG conditions. Cell viability was evaluated by flow cytometry after staining with 7-AAD. The results are expressed as % of positive cells (7AAD+) compared to uninduced-MSC (ctrl-MSC, black) and are reported as mean ± SD, N = 3.
FIGURE 4MHA/Coll-induced hBM-MSCs differentiation under MG condition. hBM-MSCs osteogenic differentiation was investigated in MHA/Coll scaffolds after 7, 14, and 21 days under G or MG conditions. The levels of the differentiation markers CD29 and CD44 were evaluated by flow cytometry. Uninduced-MSC (black) and induced-MSC (gray) were used as negative and positive control, respectively, for induced hBM-MSCs cultured on scaffolds (A). Differentiation plot displaying hBM-MSCs, which are negative for CD45 marker, and differentiated cells, which showed the loss of the differentiation marker CD29. Uninduced-MSC (black) and induced-MSC (gray) were used as negative and positive control, respectively, for induced hBM-MSCs cultured on scaffolds (B). Cell differentiation of hBM-MSCs cultured on MHA/Coll scaffolds was investigated after 21 days evaluating the expression of CD90 as a differentiation marker toward osteogenic lineage (C). The results are expressed as % of positive cells and are the average of three independent experiments. Significant differences: ***p < 0.001 and ****p < 0.0001, vs. ctrl-MSC under G condition; ####p < 0.0001, vs. ctrl-MSC under MG condition (Two-way ANOVA).
FIGURE 5Osteo-differentiation related gene expression array in G and MG conditions. (A) Heat map of 84 osteo-related genes under MG conditions indicating the difference between induced-MSC and 3D MHA/Coll scaffold, showing standardized expression levels of modulated genes for the control, induced-MSC under G and induced-MSC under MG samples, respectively (red: high gene expression; green: low gene expression; black: unmodulated genes). (B) Tables showing the main modulate genes in comparison to the uninduced control in induced-MSC and MHA/Coll under G and MG conditions, respectively. (C) Osteogenic differentiation on MHA/Coll after MG. The main genes involved in osteoblast differentiation were analyzed using Real-Time PCR: alkaline phosphatase (ALP) and osteocalcin (BGLAP). Statistical differences:; **p < 0.01; ***p < 0.001, for G group vs. ctrl G; ##p < 0.01, for MG group vs. ctrl MG (Two-way ANOVA). Bars indicate the compared samples under different conditions.